Explore the most recent editions of MPO Magazine, featuring expert commentary, industry trends, and breakthrough technologies.
Access the full digital version of MPO Magazine anytime, anywhere, with interactive content and enhanced features.
Join our community of medical device professionals. Subscribe to MPO Magazine for the latest news and updates delivered straight to your mailbox.
Explore the transformative impact of additive manufacturing on medical devices, including design flexibility and materials.
Learn about outsourcing options in the medical device sector, focusing on quality, compliance, and operational excellence.
Stay updated on the latest electronic components and technologies driving innovation in medical devices.
Discover precision machining and laser processing solutions that enhance the quality and performance of medical devices.
Explore the latest materials and their applications in medical devices, focusing on performance, biocompatibility, and regulatory compliance.
Learn about advanced molding techniques for producing high-quality, complex medical device components.
Stay informed on best practices for packaging and sterilization methods that ensure product safety and compliance.
Explore the latest trends in research and development, as well as design innovations that drive the medical device industry forward.
Discover the role of software and IT solutions in enhancing the design, functionality, and security of medical devices.
Learn about the essential testing methods and standards that ensure the safety and effectiveness of medical devices.
Stay updated on innovations in tubing and extrusion processes for medical applications, focusing on precision and reliability.
Stay ahead with real-time updates on critical news affecting the medical device industry.
Access unique content and insights not available in the print edition of the MPO Magazine.
Explore feature articles that delve into specific topics within the medical device industry, providing in-depth analysis and insights.
Gain perspective from industry experts through regular columns addressing key challenges and innovations in medical devices.
Read the editor’s thoughts on the current state of the medical device industry.
Discover the leading companies in the medical device sector, showcasing their innovations and contributions to the industry.
Explore detailed profiles of medical device contract manufacturing and service provider companies, highlighting their capabilities and offerings.
Learn about the capabilities of medical device contract manufacturing and service provider companies, showcasing their expertise and resources.
Watch informative videos featuring industry leaders discussing trends, technologies, and insights in medical devices.
Short, engaging videos providing quick insights and updates on key topics within the medical device industry.
Tune in to discussions with industry experts sharing their insights on trends, challenges, and innovations in the medical device sector.
Participate in informative webinars led by industry experts, covering various topics relevant to the medical device sector.
Stay informed on the latest press releases and announcements from leading companies in the medical device manufacturing industry.
Access comprehensive eBooks covering a range of topics on medical device manufacturing, design, and innovation.
Highlighting the innovators and entrepreneurs who are shaping the future of medical technology.
Explore sponsored articles and insights from leading companies in the medical device manufacturing sector.
Read in-depth whitepapers that explore key issues, trends, and research findings for the medical device industry.
Discover major industry events, trade shows, and conferences focused on medical devices and technology.
Get real-time updates and insights live from the CompaMed/Medica conference floor.
Join discussions and networking opportunities at the MPO Medtech Forum, focusing on the latest trends and challenges in the industry.
Attend the MPO Summit for insights and strategies from industry leaders shaping the future of medical devices.
Participate in the ODT Forum, focusing on orthopedic device trends and innovations.
Discover advertising opportunities with MPO to reach a targeted audience of medical device professionals.
Review our editorial guidelines for submissions and contributions to MPO.
Read about our commitment to protecting your privacy and personal information.
Familiarize yourself with the terms and conditions governing the use of MPOmag.com.
What are you searching for?
The game has been designed to help researchers better understand dementia by seeing how the brain works in relation to spatial navigation.
April 25, 2019
By: University of East Anglia
A specially designed mobile phone game can detect people at risk of Alzheimer’s—according to new research from the University of East Anglia. Researchers studied gaming data from an app called Sea Hero Quest, which has been downloaded and played by more than 4.3 million people worldwide. The game, created by Deutsche Telekom in partnership with Alzheimer’s Research UK, University College London (UCL), the University of East Anglia and game developers, Glitchers has been designed to help researchers better-understand dementia by seeing how the brain works in relation to spatial navigation. As players make their way through mazes of islands and icebergs, the research team are able to translate every 0.5 seconds of gameplay into scientific data. The team studied how people who are genetically pre-disposed to Alzheimer’s disease, play the game—compared to people who are not. The results, published in the journal PNAS, show that people who are genetically at risk of developing Alzheimer’s disease can be distinguished from those who are not on specific levels of the Sea Hero Quest game. The findings are particularly important because a standard memory and thinking test could not distinguish between the risk and non-risk groups. Lead researcher Prof Michael Hornberger, from UEA’s Norwich Medical School, said: “Dementia will affect 135 million people worldwide by 2050. We need to identify people earlier to reduce their risk of developing dementia in the future. “Current diagnosis of dementia is strongly based on memory symptoms, which we know now are occurring when the disease is quite advanced. Instead, emerging evidence shows that subtle spatial navigation and awareness deficits can precede memory symptoms by many years. “Our current findings show that we can reliably detect such subtle navigation changes in at-genetic-risk of Alzheimer’s disease healthy people without any problem symptoms or complaints. Our findings will inform future diagnostic recommendations and disease treatments to address this devastating disease.” The data collected by the Sea Hero Quest app is vital for research—because every two minutes spent playing the game is equal to five hours of lab-based research. And having three million players globally equates to more than 1,700 years’ worth of lab-based research. The team studied gaming data taken from 27,108 UK players aged between 50-75—the most vulnerable age-group to develop Alzheimer’s in the next decade. They compared this benchmark data with a smaller lab-based group of 60 people who underwent genetic testing. In the smaller lab group, 31 volunteers carried the APOE4 gene, which is known to be linked with Alzheimer’s disease, and 29 people did not. Both lab groups were matched for age, gender, education and nationality with the benchmark cohort. Genetic risk for Alzheimer’s is complicated. People (around one in every four) who have one copy of the APOE4 gene are around three times more likely to be affected by Alzheimer’s and develop the disease at a younger age. Prof Hornberger said: “We found that people with a high genetic risk, the APOE4 carriers, performed worse on spatial navigation tasks. They took less efficient routes to checkpoint goals. “This is really important because these are people with no memory problems. “Meanwhile, those without the APOE4 gene travelled roughly the same distance as the 27,000 people forming the baseline score. This difference in performance was particularly pronounced where the space to navigate was large and open. “It means that we can detect people who are at genetic risk of Alzheimer’s based on how they play the game.” The team have previously reported Sea Hero Quest found people in different countries and populations navigate differently. Gillian Coughlan, also from UEA’s Norwich Medical School, said: “This research shows that data collected from people who downloaded and played Sea Hero Quest can be used as a benchmark to help identify those at a genetically higher risk of developing Alzheimer’s in smaller groups of people. “Sea Hero Quest succeeded where a conventional memory and thinking test failed. It demonstrates the power of harnessing large-scale citizen science projects and applying big data technologies, to help improve the early detection of diseases like Alzheimer’s. “This global Sea Hero Quest project provides an unprecedented chance to study how many thousands of people from different countries and cultures navigate space. It is helping to shed light on how we use our brain to navigate and also to aid the development of more personalized measures for future diagnostics and drug treatment programs in dementia research. “This is the tip of the iceberg and there is still a lot more work to do to extract and capitalize on the wealth of data collected through the Deutsche Telekom’s Sea Hero Quest project.” Prof Hugo Spiers, from UCL, said: “Our discovery highlights the value of bringing together big data with precise data to aid the development of digital tools for medical diagnoses.” Hilary Evans, Chief Executive at Alzheimer’s Research UK said: “We often hear heart-breaking stories about people with dementia who get lost and can’t find their way home and we know spatial navigation difficulties like these are some of the earliest warning signs for the condition. “Research shows us that the brain changes associated with diseases like Alzheimer’s begin decades before symptoms like memory loss start and for future Alzheimer’s treatments to be effective, it’s likely they must be given at the earliest stages of disease, before there’s too much damage to the brain. “Using big data to help improve the early and accurate detection of the diseases that cause dementia can help revolutionize how we research and treat the condition. Sea Hero Quest is an amazing example of how pioneering research can help scientists get one step closer to a life-changing breakthrough.” Hans-Christian Schwingen, Chief Brand Officer at Deutsche Telekom, said: “What Sea Hero Quest has demonstrated is the unique power of innovative cross sector partnerships in advancing research. We are very proud to have been a part of facilitating such a revolutionary project and are excited to see the future insights generated through analysis of the data set collected.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !